• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Disrupted in renal carcinoma protein 1 (DIRC1)

ACP13542

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13542 Target NameDIRC1
Target SynonymsDIRC1Disrupted in renal carcinoma protein 1; Disrupted in renal cancer proteinFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-104
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ969H9
Background Information
  • Uniprot Id

    Q969H9

  • Target Species

    Human

  • Target Name

    DIRC1

  • Target Full Name

    Disrupted in renal carcinoma protein 1

  • Target Involvement

    A chromosomal aberration involving DIRC1 is associated with familial clear cell renal carcinoma (PubMed:11587072). Translocation t(2;3)(q33;q21) (PubMed:11587072).

  • Target Tissue Specificity

    Expressed at low steady-state level in adult placenta, testis, ovary, prostate, fetal kidney, spleen and skeletal muscle.

  • Target Synonyms

    DIRC1Disrupted in renal carcinoma protein 1; Disrupted in renal cancer protein

Inquire Recombinant Human Disrupted in renal carcinoma protein 1 (DIRC1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification